Evidence map›Paper›PMID 19297451›Full record

ArticleAmerican journal of physiology. Renal physiology2009

ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide.

Mukut Sharma, Zongmin Zhou, Hiroto Miura, Andreas Papapetropoulos, Ellen T McCarthy, Ram Sharma, Virginia J Savin, Elias A Lianos

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Renin-angiotensin system-mediated nitric oxide signaling in podocytes.American journal of physiology. Renal physiology · 2024
    Article
  6. Association between protein arginineJournal of clinical & translational endocrinology · 2024
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Measurement of renal function in patients with chronic kidney disease.British journal of clinical pharmacology · 2013
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mukut SharmaDivision of Nephrology, Dept. of Medicine, Kidney Disease Center, Medical College of Wisconsin, M-4160, Nephrology/CVC/MEB, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA. msharma@mcw.edu
Zongmin Zhou
Hiroto Miura
Andreas Papapetropoulos
Ellen T McCarthy
Ram Sharma
Virginia J Savin
Elias A Lianos
Medical College of Wisconsin · USNational and Kapodistrian University of Athens · GRUniversity of Kansas · US

Funding

Role of IKCa Channels in Vascular RemodelingR01HL080173 · NHLBI · UNIVERSITY OF NEVADA RENO · PI MIURA, HIROTO · 2007 to 2011
$1.9M
NHLBI NIH HHS R01 HL080173NHLBI NIH HHS R01-HL-080173PHS HHS R01-061588
6 · The paper itself

Abstract

Chronic kidney disease (CKD) is associated with decreased renal nitric oxide (NO) production and increased plasma levels of methylarginines. The naturally occurring guanidino-methylated arginines N-monomethyl-l-arginine (l-NMMA) and asymmetric dimethyl-l-arginine (ADMA) inhibit NO synthase activity. We hypothesized that ADMA and l-NMMA compromise the integrity of the glomerular filtration barrier via NO depletion. We studied the effect of ADMA on albumin permeability (P(alb)) in isolated glomeruli and examined whether this effect involves NO- and superoxide (O(2)(*-))-dependent mechanisms. ADMA at concentrations found in circulation of patients with CKD decreased cGMP and increased P(alb) in a dose-dependent manner. A similar increase in P(alb) was caused by l-NMMA but at a concentration two orders of magnitude higher than that of ADMA. NO donor DETA-NONOate or cGMP analog abrogated the effect of ADMA on P(alb). The SOD mimetic tempol or the NAD(P)H oxidase inhibitor apocynin also prevented the ADMA-induced increase in P(alb). The NO-independent soluble guanylyl cyclase (sGC) activator BAY 41-2272, at concentrations that increased glomerular cGMP production, attenuated the ADMA-induced increase in P(alb). Furthermore, sGC incapacitation by the heme site-selective inhibitor ODQ increased P(alb). We conclude that ADMA compromises the integrity of the filtration barrier by altering the bioavailability of NO and O(2)(*-) and that NO-independent activation of sGC preserves the integrity of this barrier under conditions of NO depletion. NO-independent activation of sGS may be a useful pharmacotherapeutic approach for preservation of glomerular function in CKD thereby reducing the risk for cardiovascular events.

Indexed as

AlbuminsAnimalsAnthracenesArginineFree Radical ScavengersGlomerular Basement MembraneGuanylate CyclaseMaleNADPH OxidasesNitric OxideNitric Oxide Synthaseomega-N-MethylarginineOxidation-ReductionPermeabilityPropaneRatsAlbuminsAnthracenesArginineFree Radical ScavengersGuanylate CyclaseNADPH OxidasesNitric OxideNitric Oxide SynthaseN,N-dimethylarginineomega-N-MethylargininePropaneReceptors, Cytoplasmic and NuclearSoluble Guanylyl CyclaseSuperoxides

Identifiers

PMID19297451
PMCPMC2692444
OpenAlexW2143541397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.